24.01.2025 16:29:39
|
Hoth Therapeutics Restores Compliance With Nasdaq Listing Requirements
(RTTNews) - Hoth Therapeutics, Inc. (HOTH) a New York-based biopharmaceutical company, Friday announced that it has been notified by Nasdaq's Listing Qualifications Department that it has regained compliance with the minimum bid price requirement outlined in Listing Rule 5550(a)(2).
The notification comes as the company's common stock maintained a closing bid price of $1.00 or higher for 10 consecutive business days, from January 7 to January 22, 2025.
Currently, HOTH is trading at $1.518 or 3.2720 percent higher on the Nasdaq Capital Market.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Hoth Therapeutics Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |